
Since 2017 we have been working to preserve sight.
What we do here at Globe Biomedical
Why?
Minute-by-minute ocular surface tracking will completely change how clinicians treat patients. Clinicians will use our technology to review summary statistics based on large data sets collected during daily life. Our core focus is on Intraocular pressure (IOP), the leading risk factor of glaucoma. Regular maintenance of IOP is the current standard of care, and there is no cure for any blindness caused by glaucomatous damage.
How?
Our approach is unique. Our patented technology is the only one of its kind to track eye health and seamlessly integrate it into one's lifestyle. Our sensing technology is concealed in attractive eyeglass frames. Data transfer occurs wirelessly with minimal effort by the user. And our cloud-based system doesn’t even require the patient to have a smartphone.
When?
Summer 2023 is our target launch date for our research product, which will allow industry and university researchers to capture data that was never thought possible: continuous ocular surface images all day long with no impact on the subject's daily life. In fact, they might forget they are part of a research study! We are aiming for late 2023 for the release of our consumer version, which will utilize cloud-based computer processing of the imagery to provide clinicians with ocular wellness history and trends.
By tracking intraocular pressure (IOP) continuously throughout the day, ophthalmologists and optometrists will finally have answers to questions like:
Are patients remembering to use daily medications?
Did the eye pressure exceed a preset threshold?
Which treatments are working and at what time of day?
Is the patient experiencing eye pressure spikes during the day?
Is the surface of the eye indicating any health anomalies?